The lowly leopard frog may harbor a secret weapon in the fight against malignant mesothelioma. Using a natural protein found in the leopard frog, biopharmaceutical company Alfacell has developed a therapeutic product called Onconase, which selectively targets cancerous cells and destroys them without harming healthy tissue.
As the limitations of traditional tools used to battle mesothelioma become more apparent, researchers are turning to new technologies in order to provide hope for the suffers of malignant mesothelioma.
It’s called suberoylanilide hydroxamic acid (SAHA), and it may be one of a new arsenal of drugs that doctors can use to prolong the lives of mesothelioma patients.
A Japanese pharmaceutical consortium announced the advancement of a new chemotherapy-based mesothelioma treatment option to Phase II clinical trials of patients suffering from pleural malignant mesothelioma.
